A phase II study of the PI3K inhibitor copanlisib in combination with the anti-CD20 monoclonal antibody rituximab for patients with marginal zone lymphoma: treatment rationale and protocol design of the COUP-1 trial
Grunenberg, Alexander, Kaiser, Lisa M, Woelfle, Stephanie, Schmelzle, Birgit, Viardot, Andreas, Möller, Peter, Barth, Thomas F. E, Muche, Rainer, Dreyhaupt, Jens, Raderer, Markus, Kiesewetter, Barbara, Buske, Christian
Published in BMC cancer (29.06.2021)
Published in BMC cancer (29.06.2021)
Get full text
Journal Article
Bortezomib-Dexamethasone, Rituximab, and Cyclophosphamide as First-Line Treatment for Waldenström's Macroglobulinemia: A Prospectively Randomized Trial of the European Consortium for Waldenström's Macroglobulinemia
Buske, Christian, Dimopoulos, Meletios A, Grunenberg, Alexander, Kastritis, Efstathios, Tomowiak, Cecile, Mahé, Béatrice, Troussard, Xavier, Hajek, Roman, Viardot, Andreas, Tournilhac, Olivier, Aurran, Therese, Lepretre, Stephane, Zerazhi, Hacene, Hivert, Benedicte, Leblond, Veronique, de Guibert, Sophie, Brandefors, Lena, Garcia-Sanz, Ramon, Gomes da Silva, Maria, Kimby, Eva, Schmelzle, Birgit, Kaszynski, Dajana, Dreyhaupt, Jens, Muche, Rainer, Morel, Pierre
Published in Journal of clinical oncology (10.05.2023)
Published in Journal of clinical oncology (10.05.2023)
Get full text
Journal Article
ACTR-44. PRELIMINARY RESULTS FROM THE NCT02770378 PROOF-OF-CONCEPT CLINICAL TRIAL ASSESSING THE SAFETY OF THE CUSP9v3 PROTOCOL COMBINED WITH METRONOMIC TEMOZOLOMIDE FOR RECURRENT GLIOBLASTOMA
Halatsch, Marc-Eric, Kast, Richard, Karpel-Massler, Georg, Schmidt, Carl, Schmelzle, Birgit, Awad, Fadi, Panther, Patricia, Heiland, Tim
Published in Neuro-oncology (Charlottesville, Va.) (05.11.2018)
Published in Neuro-oncology (Charlottesville, Va.) (05.11.2018)
Get full text
Journal Article
A phase Ib/IIa trial of 9 repurposed drugs combined with temozolomide for the treatment of recurrent glioblastoma: CUSP9v3
Halatsch, Marc-Eric, Kast, Richard E, Karpel-Massler, Georg, Mayer, Benjamin, Zolk, Oliver, Schmitz, Bernd, Scheuerle, Angelika, Maier, Ludwig, Bullinger, Lars, Mayer-Steinacker, Regine, Schmidt, Carl, Zeiler, Katharina, Elshaer, Ziad, Panther, Patricia, Schmelzle, Birgit, Hallmen, Anke, Dwucet, Annika, Siegelin, Markus D, Westhoff, Mike-Andrew, Beckers, Kristine, Bouche, Gauthier, Heiland, Tim
Published in Neuro-oncology advances (01.01.2021)
Published in Neuro-oncology advances (01.01.2021)
Get full text
Journal Article
CTNI-04. RECURRENT GLIOBLASTOMA LONG-TERM SURVIVORS TREATED WITH CUSP9v3
Halatsch, Marc-Eric, Kast, Richard, Karpel-Massler, Georg, Mayer, Benjamin, Zolk, Oliver, Schmitz, Bernd, Scheuerle, Angelika, Maier, Ludwig, Bullinger, Lars, Mayer-Steinacker, Regine, Schmidt, Carl, Zeiler, Katharina, Elshaer, Ziad, Panther, Patricia, Schmelzle, Birgit, Hallmen, Anke, Dwucet, Annika, Siegelin, Markus D, Westhoff, Mike-Andrew, Beckers, Kristine, Bouche, Gauthier, Heiland, Tim
Published in Neuro-oncology (Charlottesville, Va.) (12.11.2021)
Published in Neuro-oncology (Charlottesville, Va.) (12.11.2021)
Get full text
Journal Article
Phase II trial evaluating the efficacy and safety of the anti-CD20 monoclonal antibody obinutuzumab in patients with marginal zone lymphoma
Grunenberg, Alexander, Kaiser, Lisa M, Woelfle, Stephanie, Schmelzle, Birgit, Viardot, Andreas, Möller, Peter, Barth, Thomas Fe, Muche, Rainer, Dreyhaupt, Jens, Buske, Christian
Published in Future oncology (London, England) (01.05.2020)
Published in Future oncology (London, England) (01.05.2020)
Get full text
Journal Article